Literature DB >> 19205697

SUV and segmentation: pressing challenges in tumour assessment and treatment.

Giovanni Lucignani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19205697     DOI： 10.1007/s00259-009-1085-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  11 in total

Review 1.  The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective.

Authors:  G Lucignani; G Paganelli; E Bombardieri
Journal:  Nucl Med Commun       Date:  2004-07       Impact factor: 1.690

2.  Selecting the optimal image segmentation strategy in the era of multitracer multimodality imaging: a critical step for image-guided radiation therapy.

Authors:  Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-08       Impact factor: 9.236

3.  A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours.

Authors:  Hua Li; Wade L Thorstad; Kenneth J Biehl; Richard Laforest; Yi Su; Kooresh I Shoghi; Eric D Donnelly; Daniel A Low; Wei Lu
Journal:  Med Phys       Date:  2008-08       Impact factor: 4.071

4.  Threshold segmentation for PET target volume delineation in radiation treatment planning: the role of target-to-background ratio and target size.

Authors:  M Brambilla; R Matheoud; C Secco; G Loi; M Krengli; E Inglese
Journal:  Med Phys       Date:  2008-04       Impact factor: 4.071

5.  Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients.

Authors:  Hansjörg Vees; Srinivasan Senthamizhchelvan; Raymond Miralbell; Damien C Weber; Osman Ratib; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-26       Impact factor: 9.236

6.  The development and testing of a digital PET phantom for the evaluation of tumor volume segmentation techniques.

Authors:  Michalis Aristophanous; Bill C Penney; Charles A Pelizzari
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

7.  Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.

Authors:  Carlo Greco; Sadek A Nehmeh; Heiko Schöder; Mithat Gönen; Barbara Raphael; Hilda E Stambuk; John L Humm; Steven M Larson; Nancy Y Lee
Journal:  Am J Clin Oncol       Date:  2008-10       Impact factor: 2.339

8.  Exploratory identification of image-based biomarkers for solid mass pulmonary tumors.

Authors:  Ifeoma Nwogu; Jason J Corso
Journal:  Med Image Comput Comput Assist Interv       Date:  2008

9.  A theoretical framework for prescribing radiotherapy dose distributions using patient-specific biological information.

Authors:  C P South; M Partridge; P M Evans
Journal:  Med Phys       Date:  2008-10       Impact factor: 4.071

10.  Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.

Authors:  Matthias R Benz; Vladimir Evilevitch; Martin S Allen-Auerbach; Fritz C Eilber; Michael E Phelps; Johannes Czernin; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2008-06-13       Impact factor: 10.057
View more
  15 in total

1.  Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma.

Authors:  Yong-Il Kim; Yong Joong Kim; Jin Chul Paeng; Gi Jeong Cheon; Dong Soo Lee; June-Key Chung; Keon Wook Kang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-20       Impact factor: 9.236

2.  Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer.

Authors:  Yong-Il Kim; Yong Joong Kim; Jin Chul Paeng; Gi Jeong Cheon; Dong Soo Lee; June-Key Chung; Keon Wook Kang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-14       Impact factor: 9.236

3.  PET functional volume delineation: a robustness and repeatability study.

Authors:  Mathieu Hatt; Catherine Cheze Le Rest; Nidal Albarghach; Olivier Pradier; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

Review 4.  What Do We Measure in Oncology PET?

Authors:  Kyoungjune Pak; Seong-Jang Kim
Journal:  Nucl Med Mol Imaging       Date:  2016-04-18

5.  Preoperative [18F]FDG PET/CT tumour heterogeneity index in patients with uterine leiomyosarcoma: a multicentre retrospective study.

Authors:  Jeong-Won Lee; Jeong-Yeol Park; Hyun Ju Lee; Jong Jin Lee; Seung Hwan Moon; Seo Young Kang; Gi Jeong Cheon; Hyun Hoon Chung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-28       Impact factor: 9.236

Review 6.  Artificial Intelligence in Lymphoma PET Imaging:: A Scoping Review (Current Trends and Future Directions).

Authors:  Navid Hasani; Sriram S Paravastu; Faraz Farhadi; Fereshteh Yousefirizi; Michael A Morris; Arman Rahmim; Mark Roschewski; Ronald M Summers; Babak Saboury
Journal:  PET Clin       Date:  2022-01

7.  Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.

Authors:  Hongzan Sun; Jun Xin; Shaomin Zhang; Qiyong Guo; Yueyue Lu; Wei Zhai; Long Zhao; Weiai Peng; Baijun Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-25       Impact factor: 9.236

8.  FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.

Authors:  Vasavi Paidpally; Alin Chirindel; Stella Lam; Nishant Agrawal; Harry Quon; Rathan M Subramaniam
Journal:  Imaging Med       Date:  2012-12

9.  The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by (18)F-FDG-PET.

Authors:  Svetlana Chefer; Richard C Reba; Christopher Z Leyson; Jurgen Seidel; Reed F Johnson; Joseph E Blaney; Peter B Jahrling; Julie Dyall
Journal:  EJNMMI Res       Date:  2014-09-16       Impact factor: 3.138

10.  Differences among [18F]FDG PET-derived parameters in lung cancer produced by three software packages.

Authors:  Agnieszka Bos-Liedke; Paulina Cegla; Krzysztof Matuszewski; Ewelina Konstanty; Adam Piotrowski; Magdalena Gross; Julian Malicki; Maciej Kozak
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.